Subscribe To
calidi biotherapeutics announces commitment of $25 million in series b funding to advance stem cell-based platforms for the delivery and potentiation of oncolytic viruses to treat cancer
Financing led by Jackson Investment Group (JIG) with participation from calidi Cure, LLC, a consortium ...
June 23, 2023, 9:00 am